Welcome to chemicalbook!
Chinese English Japanese Germany Korea
400-158-6606
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

ChemicalBook CAS DataBase List Telaprevir

Telaprevir synthesis

2synthesis methods
Telaprevir (VX-950), marketed under the brand names Incivek and Incivo, is a pharmaceutical drug for the treatment of hepatitis C co-developed by Vertex Pharmaceuticals and Johnson & Johnson. It is a member of a class of antiviral drugs known as protease inhibitors. Specifically, telaprevir inhibits the hepatitis C viral enzyme NS3.4A serine protease. Telaprevir is only indicated for use against hepatitis C genotype 1 viral infections and has not been proven to have an effect on or being safe when used for other genotypes of the virus. The standard therapy of pegylated interferon and ribavirin is less effective on genotype 1.
Synthetic Routes
  • ROUTE 1
  • 202112074433729820.jpg

    Moni, Lisa; Banfi, Luca; Basso, Andrea; Carcone, Luca; Rasparini, Marcello; Riva, Renata. Ugi and Passerini Reactions of Biocatalytically Derived Chiral Aldehydes: Application to the Synthesis of Bicyclic Pyrrolidines and of Antiviral Agent Telaprevir. Journal of Organic Chemistry. Volume 80. Issue 7. Pages 3411-3428. Journal; Online Computer File. (2015).

  • ROUTE 2
  • 202112073267301274.jpg

    Znabet, Anass; Polak, Marloes M.; Janssen, Elwin; de Kanter, Frans J. J.; Turner, Nicholas J.; Orru, Romano V. A.; Ruijter, Eelco. A highly efficient synthesis of telaprevir by strategic use of biocatalysis and multicomponent reactions . Chemical Communications (Cambridge, United Kingdom). Volume 46. Issue 42. Pages 7918-7920. Journal. (2010).

  • ROUTE 3
  • 202112076219435189.jpg

    Zhang, Fan; Wen, Xiaoan; Xu, Qing-Long; Sun, Hongbin. Asymmetric synthesis of 3,4-disubstituted proline derivatives: Application in synthesis of hepatitis C virus protease inhibitor telaprevir. European Journal of Organic Chemistry. Volume 2014. Issue 36. Pages 8101-8109. Journal. (2014).

  • ROUTE 4
  • 202112073391633123.jpg

    Anon. Process for the preparation of telaprevir and intermediates thereof. IP.com Journal. Volume 14. Issue 1B. Pages 1-6. Journal; Patent. (2014).

  • ROUTE 5
  • 202112079085950590.jpg

    Sun, Guodong; Chen, Zongming; Zhang, Dexi; Chen, Yonghao. Method for preparing drug for treatment of hepatitis C. Assignee Sunshine Lake Pharma Co., Ltd., Peop. Rep. China. CN 104558106. (2015).

  • ROUTE 6
  • 202112075294922471.jpg

    Barth, Roland; Benito-Garagorri, David; Wilhelm, Thorsten. Process for the preparation and isolation of (S)-3-amino-N-cyclopropyl-2,2-dialkoxyhexanamide and (S)-tert-butyl [1-(cyclopropylamino)-2,2-dialkoxy-1-oxohexan-3-yl]carbamate via novel cyclic anhydrides and use thereof for the preparation of telaprevir. Assignee Sandoz AG, Switz. WO 2015036522. (2015).

  • ROUTE 7
  • 202112071894874611.jpg

    Kumar, Satish; Durvasula, Venugopal Venkatarama; Rathod, Parendu Dhirajlal; Aryan, Ram Chander. Process for the preparation of telaprevir and intermediates. Assignee Ranbaxy Laboratories Limited, India. WO 2014203208. (2014).

  • ROUTE 8
  • 202112072531794325.jpg

    Nandi, Sukumar; Sivakumaran, Meenakshisunderam. An improved process for the preparation of Telaprevir. Assignee Aurobindo Pharma Ltd., India. IN 2012CH04278. (2014).

  • ROUTE 9
  • 202112075843022128.jpg

    Chen, Youjin; Pan, Junfeng; Ma, Yaping; Yuan, Jiancheng. Process for preparation of telaprevir. Assignee Hybio Pharmaceutical Co., Ltd., Peop. Rep. China. CN 103554224. (2014).

  • ROUTE 10
  • 202112073522166284.jpg

    Li, Jinliang; Zhao, Nan; Ge, Ruijuan. Process for preparation of telaprevir and intermediates thereof. Assignee Shanghai Desano Pharmaceutical Co., Ltd., Peop. Rep. China; Shanghai Desano Chemical. CN 103570605. (2014).

202112074433729820.jpg

Moni, Lisa; Banfi, Luca; Basso, Andrea; Carcone, Luca; Rasparini, Marcello; Riva, Renata. Ugi and Passerini Reactions of Biocatalytically Derived Chiral Aldehydes: Application to the Synthesis of Bicyclic Pyrrolidines and of Antiviral Agent Telaprevir. Journal of Organic Chemistry. Volume 80. Issue 7. Pages 3411-3428. Journal; Online Computer File. (2015).

-

Yield:402957-28-2 80%

Reaction Conditions:

Stage #1:C38H57N7O7 with methanol;potassium carbonate at 20; for 0.5 h;
Stage #2: with Dess-Martin periodane in dichloromethane at 20;

Steps:

30
250 μ of saturated K2C03 was added to a solution of 14 (0.514 g, 0.75 mmol) in MeOH (20 ml) at room temperature. The reaction mixture was stirred for 30 minutes at room temperature resulting in a pale yellow suspension. After full conversion (as judged by TLC analysis), the reaction mixture was washed with 20 ml brine, the aqueous layer was washed again with 10 ml CH2C12 (2x). The organic layers were collected, dried with MgS04 and concentrated in vacuo, to yield a pale yellow solid. The yellow solid was dissolved in CH2CI2 (10 ml) and Dess-Martin periodinane (0.650 g, 1.532 mmol) was added at room temperature. The reaction mixture was stirred overnight before adding saturated NaHC03 solution (10 ml) and saturated Na2S203 solution (10 ml). This mixture was stirred for 10 minutes, separated and the aqueous layers were washed with EtOAc (2 x 10 ml). The organic layers were collected, dried with MgSC^ and concentrated in vacuo to give the crude product as an 83: 13:4 mixture of diastereomers. After silica gel flash chromatography (1% MeOH in CH2C12), 1 (0.412 mg, 0.61 mmol, 80%) was obtained as a white solid. lU NMR (500.23 MHz, DMSO-i¾: 5 = 9.19 (d, J= 1.4 Hz, 1H), 8.91 (d, J= 24.5 Hz, 1H), 8.76 (dd, J = 1.5, 2.5 Hz, 1H), 8.71 (d, J= 5.3 Hz, 1H), 8.49 (d, J= 9.2 Hz, 1H), 8.25 (d, J = 6.8 Hz, 1H), 8.21 (d, J = 8.9 Hz, 1H), 4.94 (m, 1H), 4.68 (dd, J= 6.5, 9.0 Hz, 1H), 4.53 (d, J = 9.0 Hz, 1H), 4.27 (d, J = 3.5 Hz, 1H), 3.74 (dd, J = 8.0, 10 Hz, 1H), 2.74 (m, 1H), 3.64 (d, J = 3.5 Hz, 1H), 0.92 (s, 9H), 0.87 (t, 3H), 0.84-1.40 (m, 23H), 0.65 (m, 2H), 0.56 (m, 2H); 13C NMR (125.78 MHz, CDC13): δ = 197.0 (C), 171.8 (C), 170.4 (C), 169.0 (C), 162.1 (C), 161.9 (C), 147.9 (CH), 144.0 (C), 143.4 (CH), 56.4 (CH), 56.3 (CH), 54.2 (CH), 53.4 (CH), 42.3 (CH), 41.3 (CH), 32.1 (CH), 31.8 (CH), 31.6 (CH), 29.1 (CH), 28.0 (CH), 26.4 (CH3); (cm4): 3302 (m), 2928 (m), 2858 (w), 1658 (s), 1620 (s), 1561 (s), 1442 (m); HRMS (ESI, 4500 V): m/z calcd. for C36H53N706Na+ ([M + Na]+) 702.3950, found 702.3941.

References:

VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS, WETENSCHAPPELIJK ONDERZOEK EN PATIËNTENZORG;RUIJTER, Eelco;ORRU, Romano;ZNABET, Anass;POLAK, Marloes;TURNER, Nicholas WO2011/103932, 2011, A1 Location in patent:Page/Page column 50; 51

FullText

Telaprevir Related Search: